Louise Rosenmayr-Templeton. Director, Tower Pharma Consulting, Vienna, Austria.
VIEW WEBCAST
This presentation discusses peptide characteristics, the challenges and opportunities for routes of application; formulation and stabilization approaches; and new developments in peptide delivery Including once-weekly Exenatide; CovX Body antibody scaffold; PEGylation approaches; Liraglutide; Taspogultide; SIP technology; Microjection; and Zosana Macroflux technology.